Featuring the world’s first neural synthesizer, artist Guy Ben-Ary and his collaborators will perform at the TodaysArt Festival in The Hague on 21 Sep...

On May 3rd, we had a successful LACDR Spring symposium. Traditionally the Spring symposium is an important platform for our PhD’s. We have highlightin...

Corneal transplantation is one of the most common human organ transplantations worldwide. Although the 1-year survival rate is as high as 90%, more th...

Han de Winde will step down as a member of the faculty board of the Faculty of Science from 1 September 2018. De Winde had been vice–dean at the facul...

Researching DNA material for genetic disorders using the most powerful apparatus. This is what GenomeScan, a company on the Leiden Bio Science Park, d...

Laura Heitman is awarded the 2018 EFMC runner-up prize for a Young Medicinal Chemist in Academia

Bringing together institutes and research groups, how do you do that? The Faculty of Science set up a joint research theme and financed three PhD posi...

Researchers from Leiden University will develop a new approach to study the biomarkers of Alzeimer’s disease. This approach focusses on the molecular ...

In April, the X-omics initiative was granted 17 million euros from the Dutch Organization for Scientific Research. The subsidy is part of the National...

Laura Heitman has been awarded a VIDI grant for her innovative drug research. Heitman strives to optimize a drug’s binding kinetics at its target in o...

Nine talented Leiden researchers have been awarded a Vidi subsidy by the Netherlands Organisation for Scientific Research (NWO). Vidis are intended fo...

During the annual LACDR Spring Symposium, the audience chose PhD student Rob van Wijk as best speaker. Furthermore, six PhD students won a poster priz...

Doctors are there to diagnose and treat people. But sometimes a diagnosis can’t be made or doctors differ in opinion. Luckily, Alireza Mashaghi Tabari...

Resistance to antibiotics is a major problem in health care. Thanks to a grant from the Elise Mathilde Fund and the LUF, pharmacologist dr. Coen van H...

As of April 1, 2018, Erik Danen has been appointed as Professor of Cancer drug target discovery at the Leiden Academic Centre for Drug Research (LACDR...